Results 211 to 220 of about 114,540 (260)
Some of the next articles are maybe not open access.
Probiotics and Antibiotics in IBD
Digestive Diseases, 2014The involvement of the gut microbiota in the pathogenesis of IBD is supported by many findings and is thus now commonly acknowledged. The imbalance in the composition of the microbiota (dysbiosis) observed in IBD patients is one of the strongest arguments and provides the rationale for a therapeutic manipulation of the gut microbiota.
Jørgensen, Nils B +10 more
openaire +4 more sources
Acta gastro-enterologica Belgica, 2013
The pathophysiology of inflammatory bowel disease is still incompletely understood. While the development of the immune system and the establishment of the microflora take place during infancy young patients often have a more severe and extensive disease.
De Greef, E. +4 more
openaire +2 more sources
The pathophysiology of inflammatory bowel disease is still incompletely understood. While the development of the immune system and the establishment of the microflora take place during infancy young patients often have a more severe and extensive disease.
De Greef, E. +4 more
openaire +2 more sources
Fishing for missing heritability in IBD
Nature Reviews Gastroenterology & Hepatology, 2015A genetic predisposition to IBD is widely accepted; however IBD heritability is dependent on more than the simple additive risk of genetic variants. In a new study using zebrafish, convincing evidence is presented that alterations in the epigenetic regulation of TNF might contribute to the "missing heritability" of IBD.
openaire +2 more sources
The gut-adherent microbiota of PSC–IBD is distinct to that of IBD
Gut, 2016Primary sclerosing cholangitis–IBD (PSC–IBD) is an inflammatory autoimmune hepato–biliary–enteric disease in which it is predicted that gut microbiota have potential pathophysiological effects, relevant to disease initiation and outcome. The recent article by Kummen et al 1 who reported that the gut microbiota in PSC is distinct compared with those ...
Quraishi, Mohammed Nabil +10 more
openaire +3 more sources
State of the Art: Ibd Therapy and Clinical Trials in Ibd
Inflammatory Bowel Diseases, 2005Inflammatory bowel diseases (IBD) encompass Crohn's disease and ulcerative colitis, which are diseases characterized by chronic intestinal inflammation. IBD is believed to result from predisposing genetic and environmental factors (specific antigens and pathogen-associated molecular patterns) acting on the immunoregulatory system and causing ...
Kim L, Isaacs +4 more
openaire +2 more sources
How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD. [PDF]
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract and includes both Crohn's disease and ulcerative colitis. Patients with IBD often present with abdominal pain, diarrhea, and rectal bleeding but may also have a wide variety of other symptoms such as weight loss, fever, nausea, vomiting, and possibly ...
Karen A, Chachu, Mark T, Osterman
exaly +3 more sources
IBD in 2013: enriching the therapeutic armamentarium for IBD.
Nature reviews. Gastroenterology & hepatology, 2014In 2013, several new IBD drugs, including golimumab and vedolizumab, have been approved or completed successful programmes, showing efficacy in both Crohn’s disease and ulcerative colitis. In addition, classic IBD drugs have been formulated for colonic delivery, such as budesonide MMX®, which was recently approved for mild-to-moderate ulcerative ...
Danese S, Peyrin-Biroulet L
openaire +2 more sources
IBD and genetics: new developments
Scandinavian Journal of Gastroenterology, 2003Inflammatory bowel disease (IBD) is a complex disorder with an aetiology that is only partly understood. Apart from environmental factors, inheritance contributes to IBD.Family studies show an increased risk among family members of a patient with IBD, particularly among first-degree relatives.
Oostenbrug, L. E. +3 more
openaire +4 more sources
Gastroentérologie Clinique et Biologique, 2010
Gut microbiota contains about 10(14) bacterial cells classified within 4 bacterial phyla, namely Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria. Much of the information has been generated through the application of nucleic acid-based methodologies (16S rRNA) which provide a cornerstone of microbial taxonomy.
openaire +3 more sources
Gut microbiota contains about 10(14) bacterial cells classified within 4 bacterial phyla, namely Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria. Much of the information has been generated through the application of nucleic acid-based methodologies (16S rRNA) which provide a cornerstone of microbial taxonomy.
openaire +3 more sources

